• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型糖尿病患者的局限性胰岛素源性淀粉样变:一例报告

Localized Insulin-Derived Amyloidosis in Diabetes Mellitus Type 1 Patient: A Case Report.

作者信息

Hrudka Jan, Sticová Eva, Krbcová Magdaléna, Schwarzmannová Klára

机构信息

Department of Pathology, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic.

Department of Internal Medicine, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic.

出版信息

Diagnostics (Basel). 2023 Jul 20;13(14):2415. doi: 10.3390/diagnostics13142415.

DOI:10.3390/diagnostics13142415
PMID:37510159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10378134/
Abstract

Localized insulin-derived amyloidosis (LIDA) is a rare local complication of subcutaneous insulin application occurring in patients with diabetes type 1 and 2. A 45-year-old woman with an 11-year history of insulin-dependent diabetes mellitus type 1 underwent a mini-abdominoplasty and excision of a long-standing palpable mass in left hypogastric subcutaneous tissue in the area of long-term insulin application. Histopathological examination revealed insulin amyloidosis as a substrate of the mass lesion. Several months after surgery, there was a transient improvement in previously poor diabetes compensation. In addition to local allergic reactions, abscess formation, scarring, lipoatrophy/dystrophy, and lipohypertrophy, LIDA broadens the differential diagnostic spectrum of local insulin injection complications. LIDA has been described as a cause of poor glycemia compensation, probably due to the conversion of soluble insulin into insoluble amyloid fibrils, which prevents insulin from circulating in the blood and regulating glucose blood concentration. Improvement in diabetes compensation has been described in several reports, including our case. LIDA is a rare local complication of subcutaneous insulin application; accurate diagnosis and treatment have clinical consequences. Immunohistochemical or immunofluorescence distinction from other amyloid types is highly recommended.

摘要

局限性胰岛素源性淀粉样变(LIDA)是1型和2型糖尿病患者皮下注射胰岛素后罕见的局部并发症。一名患有11年1型胰岛素依赖型糖尿病病史的45岁女性接受了小腹部整形手术,并切除了长期胰岛素注射部位左下腹皮下组织中一个长期可触及的肿块。组织病理学检查显示胰岛素淀粉样变是肿块病变的基础。手术后几个月,之前较差的糖尿病控制情况有了短暂改善。除了局部过敏反应、脓肿形成、瘢痕形成、脂肪萎缩/营养不良和脂肪增生外,LIDA还拓宽了局部胰岛素注射并发症的鉴别诊断范围。LIDA被认为是血糖控制不佳的一个原因,可能是由于可溶性胰岛素转化为不溶性淀粉样纤维,这阻止了胰岛素在血液中循环并调节血糖浓度。包括我们的病例在内,多篇报道中都描述了糖尿病控制情况的改善。LIDA是皮下注射胰岛素罕见的局部并发症;准确的诊断和治疗具有临床意义。强烈建议通过免疫组织化学或免疫荧光法与其他类型淀粉样变进行鉴别。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/10378134/36f04aecee94/diagnostics-13-02415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/10378134/36f04aecee94/diagnostics-13-02415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a7/10378134/36f04aecee94/diagnostics-13-02415-g001.jpg

相似文献

1
Localized Insulin-Derived Amyloidosis in Diabetes Mellitus Type 1 Patient: A Case Report.1型糖尿病患者的局限性胰岛素源性淀粉样变:一例报告
Diagnostics (Basel). 2023 Jul 20;13(14):2415. doi: 10.3390/diagnostics13142415.
2
Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.局部胰岛素源性淀粉样变(LIDA)的当前见解:临床病理特征与鉴别诊断
Pathol Res Pract. 2017 Oct;213(10):1237-1241. doi: 10.1016/j.prp.2017.08.013. Epub 2017 Sep 1.
3
Differences in clinicopathological characteristics between lipohypertrophy and localized insulin-derived amyloidosis: A scoping review.脂肪增生与局限性胰岛素源性淀粉样变的临床病理特征差异:一项范围综述。
Chronic Dis Transl Med. 2023 Nov 14;10(1):22-30. doi: 10.1002/cdt3.98. eCollection 2024 Mar.
4
Insulin-derived amyloidosis without a palpable mass at the insulin injection site: A report of two cases.胰岛素注射部位无触诊肿块的胰岛素源性淀粉样变:两例报告。
J Diabetes Investig. 2020 Jul;11(4):1002-1005. doi: 10.1111/jdi.13199. Epub 2020 Jan 19.
5
An abdominal wall mass of exogenous insulin amyloidosis in setting of metastatic sarcoma.转移性肉瘤背景下的外源性胰岛素淀粉样变腹壁肿块。
J Cutan Pathol. 2020 Apr;47(4):406-408. doi: 10.1111/cup.13613. Epub 2019 Dec 1.
6
Localized insulin amyloidosis with use of concentrated insulin: a potential complication.使用浓缩胰岛素导致的局部胰岛素淀粉样变:一种潜在并发症。
Diabet Med. 2016 Dec;33(12):e32-e35. doi: 10.1111/dme.13137.
7
[Insulin-derived amyloidosis (insulin ball) and skin-related complications of insulin therapy].[胰岛素源性淀粉样变(胰岛素球)及胰岛素治疗的皮肤相关并发症]
Nihon Yakurigaku Zasshi. 2023;158(2):173-177. doi: 10.1254/fpj.22109.
8
Skin-related complications of insulin therapy: epidemiology and emerging management strategies.胰岛素治疗的皮肤相关并发症:流行病学及新出现的管理策略
Am J Clin Dermatol. 2003;4(10):661-7. doi: 10.2165/00128071-200304100-00001.
9
Toxicity of insulin-derived amyloidosis: a case report.胰岛素源性淀粉样变的毒性:一例报告。
BMC Endocr Disord. 2019 Jun 13;19(1):61. doi: 10.1186/s12902-019-0385-0.
10
Localized Subcutaneous Insulin-Derived Amyloidosis Excised after Evaluation Using Ultrasonography in a Patient with Type 2 Diabetes Mellitus.2型糖尿病患者经超声评估后切除的局限性皮下胰岛素源性淀粉样变
Case Rep Endocrinol. 2017;2017:3985214. doi: 10.1155/2017/3985214. Epub 2017 Dec 18.

引用本文的文献

1
Amyloidosis Found in the Breast: A Case Report.乳房淀粉样变性病 1 例报告。
Am J Case Rep. 2024 Sep 17;25:e944755. doi: 10.12659/AJCR.944755.
2
Mechanistic Insights Behind the Self-Assembly of Human Insulin under the Influence of Surface-Engineered Gold Nanoparticles.表面工程金纳米粒子影响下人胰岛素自组装的机理研究。
ACS Chem Neurosci. 2024 Jun 5;15(11):2359-2371. doi: 10.1021/acschemneuro.4c00226. Epub 2024 May 10.
3
Fluorimetric Detection of Insulin Misfolding by Probes Derived from Functionalized Fluorene Frameworks.

本文引用的文献

1
Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort.临床实践中基于质谱的蛋白质组学淀粉样蛋白分型:来自法国全国队列的最新进展
Haematologica. 2022 Dec 1;107(12):2983-2987. doi: 10.3324/haematol.2022.281431.
2
The Pathology of Amyloidosis in Classification: A Review.淀粉样变的病理学分类:综述。
Acta Haematol. 2020;143(4):322-334. doi: 10.1159/000506696. Epub 2020 May 11.
3
Insulin-derived amyloidosis: The insulin ball, amyloidoma.胰岛素源性淀粉样变:胰岛素球、淀粉样瘤。
荧光法检测荧光芴骨架功能化探针诱导的胰岛素错误折叠
Molecules. 2024 Mar 7;29(6):1196. doi: 10.3390/molecules29061196.
JAAD Case Rep. 2020 Mar 25;6(4):351-353. doi: 10.1016/j.jdcr.2020.02.011. eCollection 2020 Apr.
4
Toxicity of insulin-derived amyloidosis: a case report.胰岛素源性淀粉样变的毒性:一例报告。
BMC Endocr Disord. 2019 Jun 13;19(1):61. doi: 10.1186/s12902-019-0385-0.
5
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.淀粉样变命名 2018:国际淀粉样变学会(ISA)命名委员会的建议。
Amyloid. 2018 Dec;25(4):215-219. doi: 10.1080/13506129.2018.1549825. Epub 2019 Jan 7.
6
Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis.肽类药物利拉鲁肽引起的新型医源性淀粉样变性:一种AL淀粉样变性的临床模拟表现
Haematologica. 2018 Dec;103(12):e610-e612. doi: 10.3324/haematol.2018.203000. Epub 2018 Sep 27.
7
Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.局部胰岛素源性淀粉样变(LIDA)的当前见解:临床病理特征与鉴别诊断
Pathol Res Pract. 2017 Oct;213(10):1237-1241. doi: 10.1016/j.prp.2017.08.013. Epub 2017 Sep 1.
8
Insulin amyloid at injection sites of patients with diabetes.糖尿病患者注射部位的胰岛素淀粉样蛋白。
Amyloid. 2016 Sep;23(3):139-147. doi: 10.1080/13506129.2016.1179183. Epub 2016 May 9.
9
Localized insulin amyloidosis with use of concentrated insulin: a potential complication.使用浓缩胰岛素导致的局部胰岛素淀粉样变:一种潜在并发症。
Diabet Med. 2016 Dec;33(12):e32-e35. doi: 10.1111/dme.13137.
10
Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes.脂肪增生对1型糖尿病患者连续血糖监测准确性的影响。
Diabetes Care. 2015 Oct;38(10):e166-7. doi: 10.2337/dc15-1267. Epub 2015 Aug 25.